Cargando…

Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Current Progresses and Challenges

The rising global prevalence of metabolic diseases has increased the prevalence of non-alcoholic fatty liver disease (NAFLD), leading to an increase in cases of NAFLD-related hepatocellular carcinoma (HCC). To provide an updated literature review detailing epidemiology, risk factors, pathogenic path...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teng, Yu-Xian, Xie, Si, Guo, Ping-Ping, Deng, Zhu-Jian, Zhang, Zi-Yi, Gao, Wei, Zhang, Wan-Guang, Zhong, Jian-Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547250/ https://www.ncbi.nlm.nih.gov/pubmed/36304509 http://dx.doi.org/10.14218/JCTH.2021.00586

Ejemplares similares

Prognosis after hepatic resection of patients with hepatocellular carcinoma related to non-alcoholic fatty liver disease: meta-analysis
por: Su, Jia-Yong, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Progresses and Challenges
por: Liu, Hao-Tian, et al.
Publicado: (2021)

Non-alcoholic fatty liver diseases: current challenges and future directions
por: Roeb, Elke
Publicado: (2021)

Epidemiology of non-alcoholic fatty liver disease and risk of hepatocellular carcinoma progression
por: Thandra, Krishna Chaitanya, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link
por: Chrysavgis, Lampros, et al.
Publicado: (2022)

Challenges and Solutions in the Management of Hepatocellular Carcinoma Associated with Non-Alcoholic Fatty Liver Disease
por: Cadar, Ramona, et al.
Publicado: (2023)

Outcomes of Liver Resection for Metabolic Dysfunction-Associated Fatty Liver Disease or Chronic Hepatitis B-Related HCC
por: Liu, Lei, et al.
Publicado: (2022)

Quantitative succinylome analysis in the liver of non-alcoholic fatty liver disease rat model
por: Cheng, Yang, et al.
Publicado: (2016)

Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?
por: Teng, Margaret LP, et al.
Publicado: (2023)

The growing threat of non-alcoholic fatty liver disease-related hepatocellular carcinoma
por: Teng, Margaret L. P., et al.
Publicado: (2022)

Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets
por: Chen, Yinshuang, et al.
Publicado: (2023)

Hepatocellular Carcinoma Due to Nonalcoholic Fatty Liver Disease: Current Concepts and Future Challenges
por: Ahmad, Muhammad Imran, et al.
Publicado: (2022)

Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease
por: Yan, Hong-Mei, et al.
Publicado: (2015)

Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy
por: Deng, Zhu-Jian, et al.
Publicado: (2022)

Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges
por: Kuchay, Mohammad Shafi, et al.
Publicado: (2021)

Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Ramai, Daryl, et al.
Publicado: (2021)

Red Blood Cell-Derived Extracellular Vesicles: An Overview of Current Research Progress, Challenges, and Opportunities
por: Ma, Si-Rui, et al.
Publicado: (2023)

Current treatment of non‐alcoholic fatty liver disease
por: Paternostro, Rafael, et al.
Publicado: (2022)

Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
por: Wong, Carrie R, et al.
Publicado: (2016)

Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma
por: Said, Adnan, et al.
Publicado: (2017)

Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma
por: Younossi, Zobair M., et al.
Publicado: (2021)

Non-alcoholic fatty liver disease-related hepatocellular carcinoma
por: Daher, Darine, et al.
Publicado: (2023)

Bioinformatics analysis of differentially expressed proteins in alcoholic fatty liver disease treated with recombinant human cytoglobin
por: Zhang, Zi-Rong, et al.
Publicado: (2021)

Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics
por: Said, Imaad, et al.
Publicado: (2022)

Inhibition of MD2‐dependent inflammation attenuates the progression of non‐alcoholic fatty liver disease
por: Zhang, Yali, et al.
Publicado: (2017)

Neutrophil‐lymphocyte ratio in relation to risk of hepatocellular carcinoma in patients with non‐alcoholic fatty liver disease
por: Thomas, Claire E., et al.
Publicado: (2022)

Microbial metabolites in non-alcoholic fatty liver disease
por: Zhou, Da, et al.
Publicado: (2019)

The Role of Fatty Acids in Non-Alcoholic Fatty Liver Disease Progression: An Update
por: Hliwa, Aleksandra, et al.
Publicado: (2021)

Clinical Experience of Acupuncture Treatment for Non-Alcoholic Fatty Liver Disease
por: Hong, Kun-Da, et al.
Publicado: (2022)

Challenges in the hepatic histopathology in non-alcoholic fatty liver disease
por: Brunt, Elizabeth M, et al.
Publicado: (2017)

Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
por: Seif El Dahan, Karim, et al.
Publicado: (2023)

Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases
por: Raff, Evan J., et al.
Publicado: (2015)

Growing challenge of post-liver transplantation non-alcoholic fatty liver disease
por: Kalogirou, Maria Styliani, et al.
Publicado: (2022)

The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
por: Yu, Siyu, et al.
Publicado: (2021)

Screening of co-pathogenic genes of non-alcoholic fatty liver disease and hepatocellular carcinoma
por: Chen, Ting, et al.
Publicado: (2022)

Is Hepatocellular Carcinoma in Fatty Liver Different to Non-Fatty Liver?
por: Nguyen, Xuan-vinh Kevin, et al.
Publicado: (2022)

Macrophages and the development and progression of non-alcoholic fatty liver disease
por: Alabdulaali, Bader, et al.
Publicado: (2023)

Liver Fibrosis in Non-Alcoholic Fatty Liver Disease and Progression to Hepatocellular Carcinoma in Patients with Inflammatory Bowel Disease: A Systematic Review
por: Martínez-Domínguez, Samuel J., et al.
Publicado: (2023)

Analysis of non-alcoholic fatty liver disease microRNA expression spectra in rat liver tissues
por: Nie, Jiao, et al.
Publicado: (2018)

Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities
por: Zhao, Chang-qing, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5bcq4e6rlradmkeo9kubmv02li